Pro Medicus (ASX:PME) Insider Purchases A$489,240.00 in Stock

Pro Medicus Limited (ASX:PMEGet Free Report) insider Sam Hupert bought 4,500 shares of the stock in a transaction on Tuesday, February 24th. The shares were bought at an average price of A$108.72 per share, for a total transaction of A$489,240.00.

Sam Hupert also recently made the following trade(s):

  • On Monday, December 22nd, Sam Hupert purchased 2,250 shares of Pro Medicus stock. The shares were bought at an average price of A$221.45 per share, with a total value of A$498,262.50.

Pro Medicus Stock Performance

The company has a market capitalization of $29.16 billion, a P/E ratio of 351.99, a P/E/G ratio of 3.87 and a beta of 0.56. The company has a debt-to-equity ratio of 1.10, a current ratio of 5.98 and a quick ratio of 4.39.

Pro Medicus Announces Dividend

The firm also recently disclosed a Interim dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 19th will be paid a $0.32 dividend. This represents a yield of 27.0%. The ex-dividend date of this dividend is Wednesday, February 25th. Pro Medicus’s dividend payout ratio is presently 56.41%.

About Pro Medicus

(Get Free Report)

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.

Recommended Stories

Insider Buying and Selling by Quarter for Pro Medicus (ASX:PME)

Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.